These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 5708468

  • 1. [New diuretic with anti-kaliuretic effect in the treatment of cirrhotic ascitis: MK 870(amyloid hydrochlorate). Clinico-humoral study].
    Schmukler B, Bisio S, Iovine E, Cervini BA.
    Prensa Med Argent; 1968 Sep 20; 55(30):1442-6. PubMed ID: 5708468
    [No Abstract] [Full Text] [Related]

  • 2. [Study of the new diuretic: Amiloride (MK-870)].
    Jenny M.
    Praxis; 1969 Sep 23; 58(38):1192-6. PubMed ID: 5395178
    [No Abstract] [Full Text] [Related]

  • 3. [Comparative study of diuretic drugs used in cirrhotic and ascitic patients].
    Lennhoff M, Duhalt R, Peña JC.
    Rev Invest Clin; 1968 Sep 23; 20(2):165-80. PubMed ID: 5721631
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of diuretic treatment on body composition in liver cirrhosis: radioisotope dilution study of the effect of amiloride (MK-870)].
    Quoidbach A, Busset R, Jenny M.
    Praxis; 1969 Sep 23; 58(38):1197-201. PubMed ID: 4910991
    [No Abstract] [Full Text] [Related]

  • 5. The effect of diuretic treatment on red cell and plasma sodium concentration in patients with hepatic cirrhosis and ascites.
    Afifi F.
    Biomedicine; 1975 Feb 28; 23(2):68-72. PubMed ID: 1156631
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Treatment of cirrhotic edemas with triamterene, amiloride and spirolactone. New clinical and biological facts].
    Vesin P.
    Schweiz Med Wochenschr; 1971 Mar 20; 101(11):398-401. PubMed ID: 5558553
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Combination of clonidine and diuretic in cirrhotic ascites with activated sympathetic nervous system: Would it be a magical bullet?
    Rai RR, Jain P.
    Hepatology; 2008 Jan 20; 47(1):360. PubMed ID: 18080335
    [No Abstract] [Full Text] [Related]

  • 10. Use of a new diuretic agent (metolazone) in patients with edema and ascites.
    Lowenthal DT, Shear L.
    Arch Intern Med; 1973 Jul 20; 132(1):38-41. PubMed ID: 4716425
    [No Abstract] [Full Text] [Related]

  • 11. [Diuretic treatment and metabolic alkalosis in ascitic liver cirrhosis].
    Grassi V, Porcellati C, Corea L, Todisco T.
    Minerva Nefrol; 1968 Jul 20; 15(4):258-60. PubMed ID: 5745815
    [No Abstract] [Full Text] [Related]

  • 12. [Diuretic therapy in the course of hepatic cirrhosis with ascites].
    Del Prete S.
    Osp Maggiore; 1965 Sep 20; 60(9):814-9. PubMed ID: 5850040
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of diuretics in the treatment of cirrhotic ascites.
    Boyer TD, Warnock DG.
    Gastroenterology; 1983 May 20; 84(5 Pt 1):1051-5. PubMed ID: 6832557
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of a 14-day administration of tolvaptan in the treatment of patients with ascites in hepatic oedema.
    Sakaida I, Yamashita S, Kobayashi T, Komatsu M, Sakai T, Komorizono Y, Okada M, Okita K, ASCITES 14-Day Administration Study Group.
    J Int Med Res; 2013 Jun 20; 41(3):835-47. PubMed ID: 23685892
    [Abstract] [Full Text] [Related]

  • 16. [Predictive analysis of the response to treatment with diuretics of patients with liver cirrhosis and ascites].
    Del Val A, Garrrigues V, Ponce J, Berenguer J.
    Rev Esp Enferm Dig; 1995 Dec 20; 87(12):859-64. PubMed ID: 8562191
    [Abstract] [Full Text] [Related]

  • 17. [Bumetanide therapy of cirrhotic ascites. Comparison of different doses and modes of administration].
    Saffiotti O, Balzano A, Rinaldi M, Savarese M, Sito M, Del Vecchio-Blanco C.
    Clin Ter; 1983 May 31; 105(4):281-8. PubMed ID: 6872470
    [No Abstract] [Full Text] [Related]

  • 18. Diagnostic usefulness of the random urine Na/K ratio in predicting therapeutic response for diuretics in cirrhotic patients with ascites.
    Mohii el SM, El Mansy IM, Salah M, Khedr MA.
    J Egypt Soc Parasitol; 2013 Dec 31; 43(3):767-76. PubMed ID: 24640876
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Treatment of ascites in liver cirrhosis].
    Geller LI.
    Sov Med; 1991 Dec 31; (5):46-7. PubMed ID: 1876922
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.